On 30 October 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. repurchased 203,000 A shares on the Shanghai Stock Exchange at a repurchase price ranging from RMB 63.20 to RMB 63.28 per share. The total consideration amounted to RMB 12,835,167.
After the repurchase, the closing balance of issued shares (excluding treasury shares) stands at 6,362,732,164, while treasury shares total 16,270,110, leading to an overall issued share count of 6,379,002,274. The repurchased shares are held as treasury shares, in compliance with the relevant listing and regulatory requirements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.